Notes / Company

Medico Remedies Ltd.

MEDICO BSE 540937 ISIN INE630Y01024 Pharmaceuticals

Fundamentals

Market cap: ₹335 cr
P/E: 25.52×
ROE: 16.16%
Debt / equity: 0.22
52-week range: 31.00 — 56.99

Research on Tijori Finance

Company snapshot

Medico Remedies Ltd.

Pharmaceuticals

₹340 cr

P/E 25.94×

Latest quarter · Mar 2026

Sales₹57 cr

Net profit₹6 cr

Op. margin+12.6%

EPS₹0.71

Strength & growth

Debt / equity0.22×

Current ratio1.68×

The timeline — 2 notes on Medico Remedies Ltd.

June 2026

29 Jun 26 · 6:14 PM IST Lead

Lead · Credit · Micro cap

Medico Remedies' credit line more than doubles to ₹42 cr, rating reaffirmed

CRISIL reaffirms BBB-/Stable while enhancing rated facilities by ₹23 cr, a key capacity move for a nano-cap exporter with 37% revenue growth.

May 2026

21 May 26 · 5:46 PM IST Brief

Brief · Earnings · Micro cap

Medico Remedies closes FY26 with 37% revenue growth, no surprises

Audited numbers confirm export-driven momentum but offer no new catalyst for a nano-cap that had already telegraphed its trajectory.

Verify on exchange BSE filings for MEDICO NSE filings for MEDICO Tijori Finance company page